Home / Taiwan Excellence Award / Award Winning Products / Product Details

RIGHTEST iFree CGM

Industry type：Health and precision instrument

Product model number：HM312

Bionime Corporation

The information related to this product could not be shown due to medical law, please contact the company directly for more information.

http://tw.bionime.com/

Contact online

About Bionime Corporation

Established in 2003, Bionime has pioneered with its brand "RIGHTEST", independently developing, designing, producing, and marketing a range of products including traditional glucose monitors and specialized hospital systems. In 2023, it became the first CGM medical device manufacturer in Taiwan approved by the Ministry of Health and Welfare. Beyond glucose management, Bionime has developed a digital ecosystem centered around users with its IoT technology team. This includes the RIGHTEST iFree CGM App, which provides real-time glucose data and dynamic curves for lifestyle improvement, and a Diabetes Management System (DMS) for healthcare providers, enhancing patient care. Additionally, the RIGHTEST Partner App allows caregivers real-time access to patient data. Aiming to be among the top global providers, Bionime’s products span various technologies and patents, with automated production systems recognized for reaching industrial 4.0 standards.

http://tw.bionime.com/

Bionime, founded in 2003, specializes in custom blood glucose monitoring systems for diabetics, internationally recognized for accuracy under its brand "RIGHTEST". Its systems, including personal (BGM and CGM) and medical (POCT) glucose management, are enhanced by an IoT-enabled app linking patients, families, and medical teams. Bionime focuses on quality and innovation, maintaining automated production for control and efficiency, holding over 400 global patents. As a leading Taiwanese brand, Rightest enhances public health with reliable products and simplifies glucose tracking for users and caregivers. It is the first in Taiwan approved by the Ministry of Health and Welfare in October 2023 for manufacturing CGM medical devices. Bionime's vertical integration strategy ensures the affordability and accessibility of its advanced CGM systems.

Contact info

Tel：04-23692388#6358

Fax：04-22617586

Email：bnc-marketing@bionime.com

Tel：04-23692388#6358

Fax：04-22617586

Email：Frank.Chen@bionime.com

Tel：04-23692388#5358

Fax：04-22617586

Email：Frank.Chen@bionime.com

Email：sharon.chen@bionime.com

Tel：04-23692388#6230